Alphy Europe is a corporate division of Amino Swiss AG
Founded in 2017 in Switzerland, in the canton of Thurgau, this business unit is engaged
in the popularization, promotion and sale of natural Astaxanthin, produced from microalgae Haematococcus pluvialis
Natural Astaxanthin in Europe at the best price. As an exclusive representative in Europe, we supply and sell the entire product range of Yunnan Alphy Biotech Co., Ltd. (China) – one of the world’s largest manufacturers of premium natural Astaxanthin. We suggest you use in your business and producing the best-in-class high-value organic products from microalgae, which have been grown in an ecologically clean region.
Stable supplies to Europe with a guarantee
Total Area: 1,000,000 m2
Productivity: 6,000 kg of pure Astaxanthin per Year
Capacity: 12,000 kg in the Period until 2020
Quality: certified Production and Laboratory
Delivery: direct Shipments from China or local Agents
Support: professional and timely
Price: excellent and competitive
Ecological natural Astaxanthin from green microalgae for following businesses
Production of food Additives and nutritional Supplements
Production of Food and Beverages for People oriented towards a healthy Lifestyle
Production of professional sports Nutrition
Production of Cosmetics
Production of animal Feed
Production of Feed and Means for the Care of Aquaculture
OUR TEAM
Karl Kirchhoff
Director Development
Competence: strategic development, management, sales, negotiations
E-mail: alphyeurope@bluewin.ch
Vladimir Kotloff
Marketing- and Sales Director
Competence: marketing, sales, web content
E-mail: kotloff@gmail.com
Yury Liaskovsky
Sales Director for Eastern Europe
Competence: sales, management, negotiations
E-mail: biotrast.by@gmail.com
Created to open you a new possibility,
Designed to facilitate your competitive fight,
Developed to give you a sustainability
Alphy Europe has a rock-solid backend for individual cooperation with each specific customer and is a heavy weight lifter by all stages of Astaxanthin supply.
Read MoreComments are closed.